Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Gestational diabetes mellitus (GDM) is increasing partly due to the obesity epidemic. Adipocytokines have thus been suggested as first trimester screening markers for GDM. In this study we explore the associations between body mass index (BMI) and serum concentrations of adiponectin, leptin, and the adiponectin/leptin ratio. Furthermore, we investigate whether these markers can improve the ability to screen for GDM in the first trimester. Methods: A cohort study in which serum adiponectin and leptin were measured between gestational weeks 6+0 and 14+0 in 2590 pregnant women, categorized into normal weight, moderately obese, or severely obese. Results: Lower concentrations of adiponectin were associated with GDM in all BMI groups; the association was more pronounced in BMI<35 kg/m Conclusions: Low adiponectin measured in the first trimester is associated with the development of GDM; higher BMI was associated with lower performance of adiponectin, though this was insignificant. Leptin had an inverse relationship with GDM in severely obese women and did not improve the ability to predict GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s88 · Cited by 916
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00008 · Cited by 291 · cited 1×
“However, there is no international consensus regarding diagnostic tests and screening methods of GDM [4].”
BackgroundAdipokines in gestational diabetes
Fasshauer, M., Blüher, M., & Stumvoll, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70176-1 · Cited by 230
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2905 · Cited by 223
Williams, M. A., Qiu, C., Muy-Rivera, M., Vadachkoria, S., Song, T., & Luthy, D. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031201 · Cited by 220
Screening for biomarkers predictive of gestational diabetes mellitus
Georgiou, H. M., Lappas, M., Georgiou, G. M., Marita, A., Bryant, V. J., Hiscock, R., Permezel, M., Khalil, Z., & Rice, G. E. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0037-8 · Cited by 151
Increased Maternal Plasma Leptin in Early Pregnancy and Risk of Gestational Diabetes Mellitus
Qiu, C., Williams, M. A., Vadachkoria, S., Frederick, I. O., & Luthy, D. A. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113621.53602.7a · Cited by 146 · cited 2×
“Studies investigating the relationship between serum leptin concentrations and the development of GDM show conflicting results [3, 10, 14, 20].”
BackgroundResultWaters, T. P., Dyer, A. R., Scholtens, D. M., Dooley, S. L., Herer, E., Lowe, L. P., Oats, J. J. N., Persson, B., Sacks, D. A., Metzger, B. E., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1194 · Cited by 111 · cited 1×
“5% depending on the diagnostic criteria used [50].”
Glucose challenge test for detecting gestational diabetes mellitus: a systematic review
van Leeuwen, M., Louwerse, M., Opmeer, B., Limpens, J., Serlie, M., Reitsma, J., & Mol, B. (2012) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03254.x · Cited by 110
Molecular Mechanisms of Diabetes and Atherosclerosis: Role of Adiponectin
Kishida, K., Funahashi, T., & Shimomura, I. (2012) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153012800493468 · Cited by 78
Maple-Brown, L., Ye, C., Hanley, A. J., Connelly, P. W., Sermer, M., Zinman, B., & Retnakaran, R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2290 · Cited by 41 · cited 4×
“Earlier studies are mainly case-control studies and a few cohort studies with a limited number of participants (maximum 817) with a low percentage of women with obesity [3, 30].”
BackgroundResultInfluential
Cited by
Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Herrera, E., & Ortega-Senovilla, H. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0978-4 · Cited by 68
Hedermann, G., Hedley, P. L., Thagaard, I. N., Krebs, L., Ekelund, C. K., Sørensen, T. I. A., & Christiansen, M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252343 · Cited by 48
“leptin and adiponectin [75, 76], indicating that the clinical presentation of PE is preceded by a foeto-maternal dyscrine condition.”
BackgroundSelf-citationNew Insights into Adipokines in Gestational Diabetes Mellitus
Valencia-Ortega, J., González-Reynoso, R., Ramos-Martínez, E. G., Ferreira-Hermosillo, A., Peña-Cano, M. I., Morales-Ávila, E., & Saucedo, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116279 · Cited by 39
“(2017) [21] Cohort 2590 (107 GDM and 2483 without GDM) classified as normal weight (18.”
BackgroundBiochemical and Molecular Biomarkers: Unraveling Their Role in Gestational Diabetes Mellitus
Karami, M., Mousavi, S. H., Rafiee, M., Heidari, R., & Shahrokhi, S. Z. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00980-8 · Cited by 33
Metadata
- Authors
- Thagaard, I. N., Krebs, L., Holm, J.-C., Lange, T., Larsen, T., & Christiansen, M.
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-01-01
- Volume
- 55
- Issue
- 11
- Pages
- 1805-1812
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2740059163
- Cited by
- 68
- References
- 12
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.